Overview
Sardar Khan-Galzie is an Urologist in Oklahoma City, Oklahoma. Dr. Khan-Galzie is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Urinary Tract Infection in Children, Muscle Invasive Bladder Cancer, Urinary Tract Infection (UTI), Ureteroscopy, and Nephrectomy. Dr. Khan-Galzie is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
608 Nw 9th St, Suite 3206, Oklahoma City, OK 73102
Mercy Clinic Oklahoma Communities
Brian Link is an Urologist in Oklahoma City, Oklahoma. Dr. Link is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Link is currently accepting new patients.
Ou Health Partners Inc
Michael Cookson is an Urologist in Oklahoma City, Oklahoma. Dr. Cookson is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Nephrectomy. Dr. Cookson is currently accepting new patients.
Ou Health Partners Inc
Brian Cross is an Urologist in Oklahoma City, Oklahoma. Dr. Cross is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Cross is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Muscle Invasive Bladder CancerDr. Khan-Galzie isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Urinary Tract Infection in ChildrenDr. Khan-Galzie isDistinguished. Learn about Urinary Tract Infection in Children.
- Advanced
- Bilateral HydronephrosisDr. Khan-Galzie isAdvanced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Khan-Galzie isAdvanced. Learn about Bladder Cancer.
- BoilsDr. Khan-Galzie isAdvanced. Learn about Boils.
- CarbuncleDr. Khan-Galzie isAdvanced. Learn about Carbuncle.
- Chromophobe Renal Cell CarcinomaDr. Khan-Galzie isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Khan-Galzie isAdvanced. Learn about Clear Cell Sarcoma.
- Experienced
- Acute CystitisDr. Khan-Galzie isExperienced. Learn about Acute Cystitis.
- Bladder Outlet ObstructionDr. Khan-Galzie isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder ReconstructionDr. Khan-Galzie isExperienced. Learn about Bladder Reconstruction.
- Eosinophilic CystitisDr. Khan-Galzie isExperienced. Learn about Eosinophilic Cystitis.
- Eunuchoidism Familial HypogonadotropicDr. Khan-Galzie isExperienced. Learn about Eunuchoidism Familial Hypogonadotropic.
- Frequent or Urgent UrinationDr. Khan-Galzie isExperienced. Learn about Frequent or Urgent Urination.